Bactiguard said today that it inked an exclusive global license agreement worth up to $5 million with Zimmer Biomet (NYSE:ZBH) to apply its infection prevention technology to Zimmer’s orthopedic trauma implants. The agreement consists of an upfront license fee of $3 million and additional contingent payments of $2 million, based on clearance and royalties on net […]